Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cardiotoxicity × salicylhydroxamic acid × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 1 Retinal Diseases 1 Myocardial Reperfusion Injury 1 Melanoma 1 Macular Degeneration 1 Choroid Diseases 1 Cardiotoxicity 1

Interventions

Trastuzumab 2 Ivabradine 2 Echocardiography 2 Bisoprolol 2 salicylhydroxamic acid 1 sacubitril and valsartan sodium hydrate drug combination 1 mitoquinone 1 epicatechin gallate 1 candesartan 1 Trimetazidine 1 Therapeutics 1 Surveys and Questionnaires 1 Spironolactone 1 Secondary Prevention 1 Restraint, Physical 1 Ramipril 1 Radiotherapy 1 Perindopril 1 Nebivolol 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Exercise 1 Cisplatin 1 Carvedilol 1 Atorvastatin 1 Antineoplastic Agents 1 Angiotensin-Converting Enzyme Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471885 2020-04-15

ERIC-ONC

University College, London

Phase NA Unknown

Myocardial Reperfusion Injury, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡